|
|
Elan Reports Fourth Quarter and Full-Year 2009 Financial Results
|
Sanofi-aventis Video Q&A: CEO Chris Viehbacher Comments on 2009 Full-Year Earnings
|
Sanofi-aventis Video Q&A : CEO Chris Viehbacher Comments on 2009 Full-Year Earnings
|
DDN Execs Coordinate Pharmaceutical Donation Drive for Haiti
|
XenoPort Announces Extension of the Horizant PDUFA Date to February 11, 2010
|
XenoPort Announces Extension of the Horizant„ PDUFA Date to February 11, 2010
|
Incyte to Report 2009 Financial Results and 2010 Financial Guidance and Provide Update on Drug Discovery & Dev
|
PicksThatMove.com Announces Investment Opinion on Lundin Mining Corporation, Aastrom Biosciences Inc., China T
|
Empire State Building and The Knot Announce the 14 Couples to Wed Atop the Landmark on ValentineEURs Weekend
|
Focus Ahead Consulting to Represent Integrated Genomics' Products and Services in Europe
|
Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Antibod
|
BioAlliance Pharma Announces Its Consolidated Turnover for 2009 a Doubling in Recurring Revenues
|
Research and Markets: Global Peritoneal Dialysis Market Report: Strategic Analysis and Opportunity Assessment
|
BSD Medical Reports Initiation of a Phase III Study on Pancreatic Cancer Using the BSD-2000 Hyperthermia Syste
|
New Lineup of Artists Join Stand Up To Cancer On Demand
|
OSI Pharmaceuticals to Announce Fourth Quarter and Year-End 2009 Financial Results on February 23, 2010
|
UnitedHealthcare Creates Adult National Cancer Care Registry with Data and Analysis to Support Oncologists in
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at t
|
Bohai Pharmaceuticals Group, Inc. Announces Ticker Symbol Change to EURBOPHEUR Effective Today
|
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
|
